CGS-24592

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCGS-24592
Drug Alias NameCGS-24592
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeprilysin inhibitors
TargetsNeprilysin
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsHypertensionHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A